New York State Common Retirement Fund’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$53.2M Hold
664,493
0.07% 193
2025
Q4
$56.6M Sell
664,493
-95,900
-13% -$7.87M 0.08% 193
2025
Q3
$59.1M Buy
760,393
+200
+0% +$15.6K 0.08% 198
2025
Q2
$59.5M Sell
760,193
-29,484
-4% -$2.2M 0.08% 201
2025
Q1
$57.2M Sell
789,677
-36,800
-4% -$2.63M 0.08% 199
2024
Q4
$61.2M Buy
826,477
+2,060
+0.2% +$144K 0.08% 194
2024
Q3
$54.4M Sell
824,417
-63,711
-7% -$4.63M 0.07% 212
2024
Q2
$82M Sell
888,128
-17,007
-2% -$1.51M 0.11% 167
2024
Q1
$86.5M Sell
905,135
-132,217
-13% -$11.1M 0.11% 158
2023
Q4
$79.1M Sell
1,037,352
-62,127
-6% -$4.32M 0.11% 169
2023
Q3
$76.2M Sell
1,099,479
-67,298
-6% -$5.41M 0.11% 162
2023
Q2
$110M Sell
1,166,777
-46,932
-4% -$4.08M 0.14% 136
2023
Q1
$100M Sell
1,213,709
-46,945
-4% -$3.69M 0.13% 141
2022
Q4
$94.1M Buy
1,260,654
+7,495
+0.6% +$578K 0.13% 147
2022
Q3
$104M Sell
1,253,159
-77,949
-6% -$7.5M 0.15% 134
2022
Q2
$127M Sell
1,331,108
-30,148
-2% -$3.12M 0.17% 121
2022
Q1
$160M Buy
1,361,256
+14,795
+1% +$1.66M 0.17% 111
2021
Q4
$174M Sell
1,346,461
-5,969
-0.4% -$696K 0.18% 111
2021
Q3
$153M Sell
1,352,430
-35,388
-3% -$4.04M 0.16% 120
2021
Q2
$144M Sell
1,387,818
-26,041
-2% -$2.45M 0.15% 131
2021
Q1
$118M Sell
1,413,859
-57,784
-4% -$4.89M 0.13% 149
2020
Q4
$134M Sell
1,471,643
-56,200
-4% -$4.66M 0.15% 134
2020
Q3
$122M Sell
1,527,843
-61,500
-4% -$4.8M 0.15% 136
2020
Q2
$110M Buy
1,589,343
+36,000
+2% +$2.56M 0.14% 143
2020
Q1
$97.7M Sell
1,553,343
-7,212
-0.5% -$520K 0.15% 139
2019
Q4
$121M Sell
1,560,555
-46,500
-3% -$3.63M 0.14% 142
2019
Q3
$118M Buy
1,607,055
+49,155
+3% +$3.45M 0.15% 135
2019
Q2
$95.9M Buy
1,557,900
+185,550
+14% +$11.2M 0.12% 170
2019
Q1
$87.5M Sell
1,372,350
-3,600
-0.3% -$205K 0.11% 175
2018
Q4
$70.3M Sell
1,375,950
-163,350
-11% -$8.26M 0.1% 194
2018
Q3
$89.3M Buy
1,539,300
+53,700
+4% +$2.63M 0.11% 186
2018
Q2
$72.1M Sell
1,485,600
-117,600
-7% -$5.49M 0.09% 211
2018
Q1
$74.6M Sell
1,603,200
-34,500
-2% -$1.5M 0.09% 215
2017
Q4
$61.5M Buy
1,637,700
+48,300
+3% +$1.77M 0.07% 259
2017
Q3
$57.9M Buy
1,589,400
+61,800
+4% +$2.36M 0.07% 260
2017
Q2
$60.2M Buy
1,527,600
+143,397
+10% +$5.23M 0.08% 247
2017
Q1
$43.4M Buy
1,384,203
+3
+0% +$94 0.06% 333
2016
Q4
$43.2M Buy
1,384,200
+7,500
+0.5% +$243K 0.06% 317
2016
Q3
$55.3M Sell
1,376,700
-151,500
-10% -$5.71M 0.08% 245
2016
Q2
$50.8M Sell
1,528,200
-594,282
-28% -$20.3M 0.07% 277
2016
Q1
$62.4M Sell
2,122,482
-27,000
-1% -$745K 0.1% 204
2015
Q4
$56.6M Sell
2,149,482
-78,720
-4% -$2.04M 0.09% 230
2015
Q3
$52.8M Sell
2,228,202
-302,064
-12% -$7.29M 0.08% 240
2015
Q2
$60.1M Sell
2,530,266
-315,048
-11% -$7.11M 0.09% 226
2015
Q1
$67.6M Sell
2,845,314
-1,013,652
-26% -$22.7M 0.1% 221
2014
Q4
$81.9M Sell
3,858,966
-754,236
-16% -$15.2M 0.12% 174
2014
Q3
$78.5M Buy
4,613,202
+546,594
+13% +$8.63M 0.12% 179
2014
Q2
$58.2M Buy
4,066,608
+2,184,048
+116% +$29.6M 0.09% 240
2014
Q1
$23.3M Sell
1,882,560
-31,800
-2% -$367K 0.04% 546
2013
Q4
$21M Sell
1,914,360
-218,400
-10% -$2.46M 0.03% 584
2013
Q3
$24.8M Buy
2,132,760
+46,200
+2% +$540K 0.04% 489
2013
Q2
$23.4M Buy
+2,086,560
New +$24.7M 0.04% 471

Other funds holding EW

New York State Common Retirement Fund's EW Position: Q1 2026 in Review

New York State Common Retirement Fund held its Edwards Lifesciences (EW) position steady in Q1 2026 at 664,493 shares worth $53.2M. The position accounts for 0.07% of the portfolio, ranked #193.

New York State Common Retirement Fund first reported a position in EW in Q2 2013 and has held it in 52 quarters since. The position peaked at $174M in Q4 2021. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • New York State Common Retirement Fund held 664,493 shares of Edwards Lifesciences worth $53.2M as of Q1 2026.
  • New York State Common Retirement Fund left its Edwards Lifesciences share count unchanged in Q1 2026.
  • Edwards Lifesciences made up 0.07% of New York State Common Retirement Fund's portfolio in Q1 2026, its #193 holding.
  • New York State Common Retirement Fund first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 52 quarters since.
  • New York State Common Retirement Fund's Edwards Lifesciences position peaked at $174M in Q4 2021.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on New York State Common Retirement Fund's 13F filing for Q1 2026, filed 6 May 2026.